| 08:50-09:05 | Welcome Remarks
Bernard A. Fox, PhD
John Wen-Cheng Chang (張文震), MD |
Plenary Session |
| 09:05-09:50 | Bridging Tumor Immune Mechanisms to Clinical Immunotherapy: Emerging Insights and Translational Strategies Speaker: Barbara Seliger, Prof. Dr., Martin Luther University Halle-Wittenberg, Germany Chair: Alice Lin-Tsing Yu (陳鈴津), MD, PhD, Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital & Chang Gung University |
| 09:50-10:35 | Guiding the Immune System: Leveraging Therapeutic Cancer Vaccines to Shape Responses in Combination Treatment Strategies Speaker: James L. Gulley, MD, PhD, National Cancer Institute(NCI), NIH, USA Chair: Huey-Kang Sytwu (司徒惠康), MD, PhD, National Health Research Institutes |
| 10:35-10:58 | Coffee Break & Networking |
| 10:58-11:43 | The Science of Tumor Infiltrating Lymphocytes (TIL) Speaker: Michael T. Lotze, MD, University of Pittsburgh School of Medicine, USA Chair: Alex Y. Chang (張元吉), MD, Linkou Chang Gung Memorial Hospital |
| 11:43-11:45 | Group Photo |
| Luncheon Symposium |
| 12:00-12:35 | #MSD Changing Clinical Practice in LA HNSCC: The Impact of Perioperative Immunotherapy from KEYNOTE-689 Speaker: Hui-Ching Wang (王慧晶), MD, PhD, Kaohsiung Medical University Hospital Chair: TBD |
| 12:35-13:10 | #Astellas From EV-302 to Taiwan Real-World: How EV+P Performs in Taiwanese LA/mUC Patients Speaker: Fu-Jen Hsueh (薛富仁), MD, National Taiwan University Hospital Chair: Mu-Hsin Chang (張牧新), MD, PhD, Taipei Veterans General Hospital |
| 12:35–13:05 | YI Poster Viewing (Authors Present) at 11th Floor Poster Area |
| 13:10-13:30 | Coffee Break & Networking |
| TOS Spring Summit |
| 13:30-13:35 | Session Opening Jen-Shi Chen (陳仁熙), MD |
| 13:35-14:15 | Redefining Outcomes in HCC: Clinical Impact of the STRIDE Regimen Speaker: Yu-Yun Shao (邵幼雲), MD, PhD, National Taiwan University Hospital Chair: Jen-Shi Chen (陳仁熙), MD, Linkou Chang Gung Memorial Hospital |
| 14:15-14:55 | Emerging Advances in Small Cell Lung Cancer Treatment Speaker: Ming-Chun Kuo (郭明濬), MD, Kaohsiung Chang Gung Memorial Hospital Chair: Peter Chiao-En Wu (吳教恩), MD, PhD, New Taipei Municipal TuCheng Hospital |
| 14:55-15:05 | Break & Networking |
| 15:05-15:45 | Redefining Adjuvant Therapy in Stage III Colon Cancer: The Emerging Role of Immunotherapy Speaker: Ching-Tso Chen (陳敬左), MD, National Taiwan University Hospital Hsinchu Branch Chair: Kun-Huei Yeh (葉坤輝), MD, PhD, National Taiwan University Hospital |
| 15:45-16:25 | Beyond TACE: Expanding IO in iHCC to Redefine Intermediate-Stage HCC Care Speaker: Chien-Huai Chuang (莊建淮), MD, National Taiwan University Cancer Center Hospital Chair: Jen-Shi Chen (陳仁熙), MD, Linkou Chang Gung Memorial Hospital |
| 16:25-16:30 | Session Closing Jen-Shi Chen (陳仁熙), MD |